The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Dynavax Technologies Corp shares valued at $140,000 were sold by Novack David F on Mar 24 ’25. At $14.00 per share, Novack David F sold 10,000 shares. The insider’s holdings dropped to 8,078 shares worth approximately $79325.96 following the completion of this transaction.
Also, DAVID NOVACK purchased 10,000 shares, netting a total of over 140,000 in proceeds.
Before that, Novack David F had sold 14,020 shares from its account. In a trade valued at $190,392, the President & COO traded Dynavax Technologies Corp shares for $13.58 each. Upon closing the transaction, the insider’s holdings decreased to 14,020 shares, worth approximately $79325.96.
As published in a research note from Goldman on February 11, 2025, Dynavax Technologies Corp [DVAX] has been rated down from a Neutral to a Sell and the price target has been revised to $12 from $15. Analysts at Goldman started covering the stock with ‘”a Neutral”‘ outlook in a report released in early February. As of September 27, 2022, JMP Securities has initiated its “Mkt outperform” rating for DVAX.
Analyzing DVAX Stock Performance
During the last five days, there has been a surge of approximately 3.26%. Over the course of the year, Dynavax Technologies Corp shares have dropped approximately -23.10%. Shares of the company reached a 52-week high of $14.63 on 03/07/25 and a 52-week low of $9.22 on 05/14/25.
Support And Resistance Levels for Dynavax Technologies Corp (DVAX)
According to the 24-hour chart, there is a support level at 9.73, which, if violated, would cause prices to drop to 9.65. In the upper region, resistance lies at 9.98. The next price resistance is at 10.14. RSI (Relative Strength Index) is 40.36 on the 14-day chart, showing neutral technical sentiment.
